Overall rank by patents
#24,529
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 27 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients).
The verdict
According to USPTO PatentsView, Imerys ranks #24,529 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 27 technology areas.
USPTO PatentsView assignee plate
Corpus R24529 · Foreign Corporation #24,529 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: ICE Data, Lp (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Imerys Minerals · this assignee
46 score
3D Lighting Innovati… · lowest
7 score
What this shows Imerys's Innovation Score is 45.7/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Imerys Minerals Limited is a focused PatentsView assignee: 27 CPC subclasses with 36.4% of grants classified under C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2017. By volume, Imerys sits between ICE Data, Lp and INDI Molecular, Inc..
Imerys Minerals Limited shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ICE Data, LP
11 patents
ID TECHNOLOGY LLC
11 patents
IMCYSE SA
11 patents
IMERGY POWER SYSTEMS, INC.
11 patents
IMMODULON THERAPEUTICS LIMITED
11 patents
IMPACT THERAPEUTICS, INC.
11 patents
IMPULSE DOWNHOLE SOLUTIONS LTD.
11 patents
INDI MOLECULAR, INC.
11 patents
IMERYS MINERALS LIMITED
11 patents
What this shows Imerys holds 11 patents at rank #24,507, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,507 in granted patent volume.
Other assignees with the most granted patents in Imerys's primary technology class.
Imerys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2018 | 5 | 45.5% |
| 2022 | 1 | 9.1% |
Top 15 of 27 technology areas
Overall rank by patents
#24,529
of 50,000 tracked assignees
45.7 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.